Cartalax Pre-mixed Pen 20/10mg

Cartalax Cartilage-Derived Tetrapeptide

Cartalax is a synthetic tetrapeptide (Ala-Glu-Asp-Pro) derived from cartilage tissue. It belongs to the class of short regulatory peptides (cytomedines) known for their tissue-specific reparative and protective effects.

Key Characteristics:

• Sequence: Ala-Glu-Asp-Pro (AEDP)

• Origin: Bioregulator peptide originally isolated from bovine cartilage

• Mechanism: Selectively targets chondrocytes and cartilage tissue; modulates gene expression to support cartilage matrix synthesis and inhibit degradation

• Properties: High tissue specificity, excellent safety profile, and low molecular weight for good bioavailability

Research Applications:

• Cartilage regeneration and joint repair studies

• Osteoarthritis and degenerative joint disease models

• Chondrocyte proliferation and extracellular matrix production

• Reduction of cartilage inflammation and degradation

• Support for bone-cartilage interface recovery

• Age-related joint degeneration research

Cartalax is studied for its ability to normalize cartilage metabolism by stimulating proteoglycan and collagen synthesis while reducing catabolic processes. It is commonly used in bioregulator research focused on musculoskeletal system restoration and joint health.

For laboratory research use only. Not intended for human or veterinary use.